Vimarsana
Biggest News Aggregation in the World

Serological Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Serological Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Serological Test Today - Breaking & Trending Today

Antibody Testing Market estimated to surge ahead at a CAGR of 7.6% to reach a Revenue of US$ 17.7 Bn by the end of 2033 - Vimarsana News

Antibody Testing Market estimated to surge ahead at a CAGR of 7.6% to reach a Revenue of US$ 17.7 Bn by the end of 2033

Antibody Testing Market Segmented By Serological Test Kit, Immunoglobulin Kits, Lateral Flow Assay Kits, Chemicals and Reagents, Consumables Products

Lyme Disease Diagnostic Devices Market Share Worth US$3.7 billion by 2027 - New Research Report by IndustryARC - Vimarsana News

Lyme Disease Diagnostic Devices Market Share Worth US$3.7 billion by 2027 - New Research Report by IndustryARC

Need for precision diagnostic instruments is increasing which is propelling the lyme disease diagnostic devices market.

COVID-19 official counts can miss mild cases – here's how serosurveys that analyze blood for signs of past infection can help - Vimarsana News

COVID-19 official counts can miss mild cases – here's how serosurveys that analyze blood for signs of past infection can help

Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis - Vimarsana News

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

The current study discusses a reliable ELISA that can detect three isotypes of antibody against three SARS-CoV-2 antigens.

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population - Vimarsana News

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

Researchers performed a cross-sectional study in the city of Bangui, the capital of the Central African Republic from July 12, 2021, to August 20, 2021.